Witness the spark in science when students compete for $3,000 cash prize!
Join us for Science Spark 3K Pitch Competition presented by the Bioscience Association Manitoba (BAM) on April 8, 2024
Join us for Science Spark 3K Pitch Competition presented by the Bioscience Association Manitoba (BAM) on April 8, 2024
Six funded projects include neurogenetics, water safety in First Nation communities and much more.
Today, Research Manitoba announces a total investment of $4,725,544 in provincial matching funds for three projects supported through the Canada Foundation for Innovation’s (CFI)…
The PharmEng team will be displaying at the American Biomanufacturing Summit on April 10 and 11th, 2024.
This conference provides the opportunity to network and meet on a one-to-one basis with…
Roche raised the curtain on its upcoming continuous glucose monitoring system featuring artificial intelligence-powered forecasts of blood sugar highs and lows.
At the International Conference…
Kane Biotech Inc. announces that at the Bioscience Association of Manitoba (“BAM”) annual awards dinner held on March 7, 2024, Kane Biotech received the BAM Company of the Year award.
IgE-mediated food allergy represents a critical global health issue and a considerable societal challenge, particularly in Europe.
Tech Manitoba hosted its first-ever “Mb Tech Week“ from February 26 to March 3, 2024. The week-long event shone a spotlight on some of the innovators and achievers from Manitoba’s tech community.
In June 2022, the Government of Canada established a long-term agreement with Moderna for the domestic production of messenger RNA (mRNA) vaccines in Canada.
Jasmyne Storm, a Master of Science student in Bioscience, Technology, and Public Policy, is helping put exciting research from UWinnipeg on the map.
Research Manitoba is pleased to announce that Jennifer Cleary is joining the organization as CEO, as of February 27, 2024.
Bioscience Association Manitoba (BAM) is pleased to host its Annual Awards Dinner, ‘Bridging Innovative Opportunities in Manitoba’ on March 7, 2024, to celebrate the accomplishments and future potential of the bioscience industry in Manitoba.
The Hamdan Bin Rashid Cancer Hospital will elevate the standard of cancer care in Dubai with accessible and specialized multidisciplinary care
VYALEV is the first-and-only subcutaneous 24-hour infusion of levodopa-based therapy for the treatment of advanced Parkinson’s disease (aPD) in Canada.
Today, Boehringer Ingelheim and CBmed GmbH Center for Biomarker Research in Medicine (CBmed) announced a long-term strategic partnership.
Cytophage Technologies Ltd. is pleased to announce that it has received its final bulletin from the TSX Venture Exchange Inc., and is scheduled to commence trading on February 9th, 2024.
Digital technology & automation have become a cornerstone in the realm of pharmaceutical manufacturing, revolutionizing processes to enhance efficiency and uphold stringent quality standards.
The Nunavut Lands and Resources Devolution Agreement, the largest land transfer in Canada’s history, was signed on January 18, 2024.
Kane Biotech Inc. announces that the Company will present its revyve™ Antimicrobial Wound Gel at the Boswick Burn and Wound Care Symposium today.
Hundreds of Manitobans are looking for professional help as a way to treat their sleepless nights.
The province’s publicly run Behavioural Sleep Medicine Clinic saw more than 1,300 referrals to its clinic last year. More than 400 were treated.
Medicure’s Vice President of Business Development, Reuben Saba, PhD is being recognized among the 50 Most Influential Leaders in the US Pharmacy Sector by Pharmacy Podcast Network for his work with Medicure’s subsidiary – Marley Drug.
Sign up for one of BAM's newsletter to learn more about bioscience, happenings in Manitoba's bioeconomy, industry conferences, and BAM training events.